InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Smith W Bradford, Chief Financial Officer. Officer active across 2 companies, notably Homology Medicines, Inc.. Aggregated, 4 filings have been recorded. The latest transaction was disclosed on 14 May 2026 — Disposition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
0640 shares0
Common Stock
SEC:0001193125-26-227500·
0640 shares0
Common Stock
SEC:0001193125-26-227500:0·
6,600 shares
Common Stock
SEC:0000899243-22-001749·
6,600 shares
Common Stock
SEC:0000899243-22-001749:0·
4 of 4 declarations
About Smith W Bradford
W. Bradford Smith is the CFO & Treasurer at Homology Medicines, Inc. and Lyra Therapeutics, Inc. He oversees the financial operations of both companies, including budgeting and financial reporting. With significant experience in finance, Smith plays a key role in managing financial resources and growth strategy.
